Vetcontact
Bayer Novartis Boehringer-Ingelheim Virbac France
Vetcontact Events Presentations Posters Case Studies Speciality Organisations
CPD Forum Products Login/Newsletter
Dentistry Home DENTISTRY
ORAL PREDNISOLONE AND THE RISK OF LAMINITIS IN HORSES
It is accepted among equine practitioners that glucocorticoid treatment is a risk factor for the development of laminitis. However, there is little published evidence of a link between glucocorticoids and laminitis. Especially triamcinolone was thought to be a risk factor. This retrospective case–control study determines whether horses receiving oral prednisolone are at increased risk of laminitis.

Clinical records of horses registered with the ambulatory service at Liphook Equine Hospital between January 2001 and November 2014 were reviewed retrospectively to identify horses that had received treatment with oral prednisolone.

For each treated horse, 2 time-matched controls that received veterinary attention but were not treated with prednisolone were selected.

Incidence of laminitis was compared between the 2 groups and factors associated with laminitis were assessed using Cox regression analysis.

Of the 416 horses treated with prednisolone, 16 (3.8%) were diagnosed with laminitis subsequent to the initiation of prednisolone treatment with an overall incidence of 2.60 (95% CI 1.49–4.22) cases per 100 horse-years at risk.

A total of 7 horses (1.7%) developed laminitis during the course of their treatment and 3 (0.7%) of the horses treated with prednisolone were ultimately subjected to euthanasia as a result of laminitis.

A total of 46 (5.7%), of the 814 time-matched control horses were diagnosed with laminitis during the study period with an overall incidence of 3.46 (95% CI 2.54–4.62) cases per 100 horse-years at risk.

Of these, 12 (1.5%) were subjected to euthanasia as a result of laminitis.

There were no significant differences in the overall laminitis incidence rate (P = 0.8), incidence rate during prednisolone treatment (P = 0.09), or probability of laminitis (P = 0.3) between the 2 groups.

Mean survival time was greater in the prednisolone than the control group. Equine metabolic syndrome and increasing age were associated with increased risk of laminitis.

Conclusions: Administration of oral prednisolone did not increase the risk of laminitis.


Source: Jordan, V. J., Ireland, J. L. and Rendle, D. I. (2016), Does oral prednisolone treatment increase the incidence of acute laminitis?. Equine Veterinary Journal. doi: 10.1111/evj.12565


Tell a friend   |   Print version   |   Send this article

Zahn um Zahn ...
Severe complications of cheek tooth extraction in a pony Due to their long hypsodont reserve crowns, extraction of equid cheek teeth can be difficult and result in more complications than the extraction of their shorter brachydont counterparts although the more recent resumption of oral extraction has greatly reduced such complications. This case report describes uncommon complications which finally were managed successfully.

  • Toll-like receptor and cytokine messenger RNA levels in equine periodontitis
  • Repeatability of an oral glucose test in ponies.
  • Orthodontic correction of `parrot mouth` in 73 foals
  • Oral direct factor Xa inhibitor anticoagulant in healthy adult horses
  • Odontoclastic tooth resorption and hypercementosis in horses
  • Raw beef bones to reduce dental calculus
  • Shear mouth in two horses associated with ipsilateral painful dental disease
  • Shear mouth in two horses associated with ipsilateral painful dental disease
  • Disposition of Extended Release Levetiracetam After Single Oral Dosing
  • Diagnostic imaging in equine dental diseases
  • Successful treatment of persistent oral papillomatosis with a recombinant oral vaccine
  • Secondary dentinal problems in cheek teeth of horses with pulpitis
  • Paranasal sinus fibromatosis in a middle-aged horse
  • Equine dental disorders - a review
  • Gemcitabine as radiosensitizer for nonresectable oral SCC in cats
  • AAHA dental guidelines will be released soon
  • Hypercalcemia caused by oral neoplasia
  • Piroxicam and carboplatin in canine oral non-tonsillar squamous cell carcinoma
  • Who knows Porphyromonas gulae, salivosa and denticani?
  • January is the month of `Pets Dental Care`
  • Oral recombinant vaccine in therapy-resistant oral papillomatosis
  • Periapical curettage in infected mandibular cheek teeth
  • Mandibular Reconstruction of a Partial Hemimandibulectomy in a Dog (Case Report)
  • Dentinal hypersensitivity in small animals
  • Oral home care in dogs with gingivitis
  • Recommendations for dental care in geriatric patients
  • When should patients with dental problems be referred?



  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved